Lucira Health Inc (LHDX) Stock Falls -10.99% This Week; Should You Buy?
Monday, January 10, 2022 09:52 AM | InvestorsObserver Analysts
Mentioned in this article
Lucira Health Inc (LHDX) stock is down -68.53% since Friday, February 5, 2021 when the stock began trading, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives LHDX stock a score of 26 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 12. LHDX's rank also includes a fundamental score of 25. In addition to the average rating from Wall Street analysts, LHDX stock has a mean target price of $8.00. This means analysts expect the stock to climb 1.78% over the next 12 months. The long-term technical score for LHDX is 41.
LHDX has an Overall Score of 26. Find out what this means to you and get the rest of the rankings on LHDX!
Lucira Health Inc (LHDX) stock has risen 9.62% while the S&P 500 is down -0.99% as of 9:50 AM on Monday, Jan 10. LHDX is higher by $0.69 from the previous closing price of $7.17 on volume of 44,045 shares. Over the past year the S&P 500 has gained 19.14% while LHDX is down -68.53%. LHDX lost -$1.94 per share in the over the last 12 months.
Click Here to get the full Stock Report for Lucira Health Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
